Acetylsalicylic anhydride is a compound that is not commonly encountered in the literature. It is possible that it refers to a misnomer or an outdated name. The more familiar and correct name for the compound is **acetylsalicylic acid**, which is more commonly known as **aspirin**. Aspirin is a widely used nonsteroidal anti-inflammatory drug (NSAID) that is synthesized by reacting salicylic acid with acetic anhydride. It is effective in reducing pain, fever, and inflammation. Aspirin's mechanism of action involves inhibiting the production of prostaglandins, which are chemicals that contribute to pain, fever, and inflammation. The compound is studied extensively due to its various pharmacological effects, including its anti-inflammatory, analgesic, antipyretic, and antiplatelet properties. It is also being investigated for its potential to prevent certain types of cancer and cardiovascular disease.'
acetylsalicylic anhydride: impurity in aspirin; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 15110 |
| SCHEMBL ID | 789771 |
| MeSH ID | M0084642 |
| Synonym |
|---|
| nsc 63848 |
| brn 2015320 |
| einecs 215-987-5 |
| nsc 80056 |
| salicylic acid, acetate, anhydride |
| 2-(acetyloxy)benzoic acid anhydride |
| 2-acetoxybenzoic anhydride |
| benzoic acid, 2-(acetyloxy)-, anhydride |
| contraflu |
| pircan |
| acetylsalicylic anhydride |
| nsc63848 |
| nsc-63848 |
| salicylic anhydride, diacetate |
| salicylic acid acetate, anhydride |
| acetylsalicylic acid anhydride |
| vigal |
| 1466-82-6 |
| aspirin anhydride |
| nsc-80056 |
| nsc80056 |
| NCIOPEN2_008010 |
| (2-acetyloxybenzoyl) 2-acetyloxybenzoate |
| A808537 |
| unii-xia5z82rhb |
| xia5z82rhb , |
| o-acetylsalicylic anhydride |
| FT-0633573 |
| AKOS015888849 |
| 2-(acetyloxy)benzoic anhydride |
| carbasalate calcium impurity a [ep impurity] |
| salicylic anhydride diacetate |
| acetylsalicylic acid impurity f [ep impurity] |
| OAWXYINGQXLWOE-UHFFFAOYSA-N |
| SCHEMBL789771 |
| acetylsalicylic anhydride (aspirin impurity f), pharmaceutical secondary standard; certified reference material |
| DTXSID90163416 |
| CS-W007193 |
| mfcd00013236 |
| 2-(acetyloxy)benzoic anhydride (acetylsalicylic anhydride) |
| J-008244 |
| 2-acetoxybenzoicanhydride |
| DS-6612 |
| aspirinanhydride |
| aspirin impurity f |
| BCP07100 |
| ?acetylsalicylic anhydride |
| aspirin impurity f; acetylsalicylic acid impurity d; salicylic acid acetate anhydride; 2-(acetyloxy)benzoic acid 1,1'-anhydride; 2-acetoxybenzoic anhydride; aspirin anhydride |
| benzoic acid, 2-(acetyloxy)-, 1,1'-anhydride |
| Q27293845 |
| BAA46682 |
| EN300-341822 |
| 2-(acetyloxy)benzoyl 2-(acetyloxy)benzoate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.84) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||